Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference MarketScreener

AUSTIN, TX and DURHAM, NC, April 03, 2023 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in the 22nd Annual Needham Virtual Healthcare Conference being held April 17-20, 2023. Presentation Details Conference: Needham 22nd Annual Healthcare Conference Format: Fireside chat with covering analyst Gil Blum, Ph.D. Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer and Andrew Neill, M.B.A., Shattuck’s Chief Financial Officer Date:…